Urology Times 50 Innovations Series: LHRH analogues in prostate cancer

EP: 1.Urology Times 50 Innovations Series: PSA testing

EP: 2.Urology Times 50 Innovations Series: Testosterone therapy

EP: 3.Urology Times 50 Innovations Series: Stem cell–derived therapy for stress urinary incontinence

EP: 4.Urology Times 50 Innovations Series: Tissue engineering and regenerative medicine

EP: 5.50th Anniversary Innovation Celebration: The midurethral sling for stress urinary incontinence

EP: 6.Urology Times 50 Innovations Series: Genetic testing for prostate cancer

EP: 7.Urology Times 50 Innovations Series: Onabotulinumtoxin A for overactive bladder

EP: 8.Urology Times 50 Innovations Series: Clean intermittent catheterization

EP: 9.Urology Times 50 Innovations Series: Viagra for treatment of erectile dysfunction

EP: 10.Urology Times 50 Innovations Series: Active surveillance for prostate cancer

EP: 11.Urology Times 50 Innovations Series: BCG therapy for bladder cancer

EP: 12.Urology Times 50 Innovations Series: Extracorporeal shock wave lithotripsy for stones

EP: 13.Urology Times 50 Innovations Series: Treatment of female hypoactive sexual desire disorder

EP: 14.Urology Times 50 Innovations Series: Cryotherapy for kidney and prostate cancer

EP: 15.Urology Times 50 Innovations Series: Intralesional therapies for Peyronie's disease

EP: 16.Urology Times 50 Innovations Series: Radiation therapy for prostate cancer

EP: 17.Urology Times 50 Innovations Series: β3 agonists for overactive bladder

EP: 18.Urology Times 50 Innovations Series: Microsurgical testicular sperm extraction

EP: 19.Urology Times 50 Innovations Series: Anatomic radical prostatectomy

EP: 20.Urology Times 50 Innovations Series: Dr. Kelvin Moses on sipuleucel-T for mCRPC

EP: 21.Urology Times 50 Innovations Series: Dr. Jennifer Linehan on HIFU for prostate cancer

EP: 22.Urology Times 50 Innovations Series: Transrectal ultrasound-based prostate biopsy

EP: 23.Urology Times 50 Innovations Series: Neobladder reconstruction

EP: 24.Urology Times 50 Innovations Series: Multichannel urodynamics

EP: 25.Urology Times 50 Innovations Series: Treatments for male infertility

EP: 26.Urology Times 50 Innovations Series: Urinary molecular biomarkers in prostate cancer

EP: 27.Urology Times 50 Innovations Series: Blue light cystoscopy for the detection of bladder cancer

Now Viewing

EP: 28.Urology Times 50 Innovations Series: LHRH analogues in prostate cancer

EP: 29.Urology Times 50 Innovations Series: Advancements in vesicovaginal fistula repair

EP: 30.Urology Times 50 Innovations Series: Artificial urinary sphincter

EP: 31.Urology Times 50 Innovations Series: PSMA-PET imaging in prostate cancer

EP: 32.Urology Times 50 Innovations Series: Sacral neuromodulation

EP: 33.Urology Times 50 Innovations Series: Penile prostheses

EP: 34.Urology Times 50 Innovations Series: Multiparametric MRI in prostate cancer

EP: 35.Urology Times 50 Innovations Series: Intracavernosal injections for erectile dysfunction

EP: 36.Urology Times 50 Innovations Series: Bulking injections for stress urinary incontinence

EP: 37.Dr. Gill explains the importance of BPH treatment innovations to urology

EP: 38.50th Anniversary Innovation Celebration: Buccal mucosa grafts for urethral strictures

As part of the Urology Times' 50th Anniversary Innovation Celebration, E. David Crawford, MD, discusses the development of luteinizing hormone-releasing hormone (LHRH) agonists and antagonists in prostate cancer. Crawford is a professor of urology at the University of California, San Diego.